Julphar & MSD Shortlisted for Alliance Award
Julphar, among the largest generic pharmaceutical manufacturers in the MENA region, in addition to its alliance partner, MSD, has been shortlisted for the 2018 Organization of Strategic Alliance Professionals (ASAP) awards.
This is the first time a pharmaceutical company from the MEA region has been shortlisted for the award and highlights the contributions both organizations are supplying in alliance management in order to help produce a stronger profession.
MSD (Merck in the US and Canada) is a global healthcare provider and one of the biggest pharmaceutical business in the world. Julphar signed a five-year licensing take care of the company in 2014, offering it exclusive legal rights to manufacture, market, distribute and market particular MSD products in UAE, Kuwait, Bahrain, Oman, Qatar and Iraq.
Discussing the statement, Jerome Carle, Julphar General Manager, said: "It is an honor to be shortlisted for this distinguished award. Considering that beginning, our partnership with MSD has actually aided us to boost ease of access and create greater value for all our stakeholders".
" Being shortlisted is a clear sign that our alliance is including worth to clients and the healthcare system in the region. It additionally demonstrates how a global pharmaceutical company can work effectively with one more terrific regional gamer and produce a partnership that brings worth to the health community of the region.
" We have a bright present and exciting future and, with our partnership, we will certainly continuously push the benchmark for excellence and address individuals' requirements in the region."
ASAP is the leading global expert association devoted to discussing, planning and performing partnerships and other collaborative business partnerships. The association gives its participants discussion forums for networking and professional development along with accessibility to devices and sources, while functioning to raise and advertise the technique of alliance administration.
Mazen Altaruti, AVP Managing Director GCC - DSM, said: "It is great news to be selected as a finalist in the 2018 ASAP Partnership Excellence Awards. We strongly believe that our partnership adds worth to individuals in the region and plays a crucial duty in the medical care industry.
" Our partnership with Julphar has actually enabled us to concentrate on finding innovative means to resolve critical diseases and has actually offered us a further connection with customers and a region-wide focus on their medical care needs."
Award winners will be introduced at the ASAP Global Partnership Summit in Fort Lauderdale, Florida in the USA on March 27th, 2018.
